23 julio 2015
Two different classes of drugs, aromatase inhibitors and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer, two recent studies indicate. Moreover, the researchers suggest that the two types of drug can be used together, increasing the benefits while also decreasing some side-effects.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/cQIIFM0PbUs» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/cQIIFM0PbUs/150723190530.htm
